Ehsi.Pk
EHSI.PK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.
Business. EHSI.PK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
EHSI.PK operates in the healthcare facilities and services industry, providing biotechnology-related services and equipment.
EHSI.PK exhibits a strong liquidity position, with a current ratio of 3.35, indicating that the company has more than three times the current assets to cover its current liabilities. The company holds $3.76 million in cash and equivalents, which is a significant portion of its total assets of $6.66 million. Despite this, the company reported negative operating cash flow of $2.94 million and free cash flow of $8.81 million, suggesting that it is not generating sufficient cash from operations to sustain its activities.
Profitability metrics for EHSI.PK are negative, with a return on equity of -1.4688 and a return on assets of -1.1711, both significantly below the industry median for healthcare facilities and services. The company reported a net loss of $7.8 million, with operating income also in the red at $7.82 million. These figures indicate that the company is not currently profitable and is struggling to generate positive returns for its shareholders.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification reported. This lack of diversification increases the company's exposure to market-specific risks and could limit its growth potential. The company's revenue of $1.02 million is relatively small compared to its peers in the healthcare sector, and there is no indication of significant revenue growth in the near term.
Looking ahead, EHSI.PK is expected to maintain its current revenue level, with no significant growth anticipated in the next fiscal year. The company's negative operating and free cash flows suggest that it may need to rely on external financing to fund its operations, although there are no immediate liquidity or dilution flags reported. The risk assessment indicates that the company has a low probability of dilution in the near term, but the lack of profitability and cash flow generation remains a concern.
Recent filings and transcripts do not indicate any major events or strategic shifts for EHSI.PK. The company has not disclosed any new product launches, partnerships, or market expansions that could drive future growth. The absence of recent strategic developments suggests that the company may be in a holding pattern, with limited visibility into its long-term growth prospects.
- EHSI.PK has a strong liquidity position with a current ratio of 3.35 and $3.76 million in cash and equivalents.
- The company is not currently profitable, with a return on equity of -1.4688 and a return on assets of -1.1711.
- Revenue is concentrated in a single business segment, with no geographic diversification reported.
- The company is expected to maintain its current revenue level, with no significant growth anticipated in the next fiscal year.
- There are no immediate liquidity or dilution flags, but the lack of profitability and cash flow generation remains a concern.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- EHSI.PK Market data — financials · 2026-05-27
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating income (YoY) (2025-12-31 vs 2024-12-31): -114.1%Derived (calculated)
- Return on equity (FY 2025-12-31): -146.9%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -6.8%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 844.8%Derived (calculated)
- Net margin (FY 2025-12-31): -762.1%Derived (calculated)
- Gross margin (FY 2025-12-31): 11.5%Derived (calculated)
- Return on assets (FY 2025-12-31): -117.1%Derived (calculated)
- Current ratio (FY 2025-12-31): 3.35xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.25xDerived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 27.2%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 54.2%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -279.8%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -169.2%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -94.1%Derived (calculated)
- Shareholders' equity (annual): USD 5.31MSEC XBRL filing
- Cash & equivalents (annual): USD 3.76MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
- Operating income (annual): USD -3.84MSEC XBRL filing
- Gross profit (annual): USD 118KSEC XBRL filing
- Total assets (annual): USD 6.66MSEC XBRL filing
- Revenue (annual): USD 1.02MSEC XBRL filing
- Net income (annual): USD -7.8MSEC XBRL filing
- Pre-tax income (annual): USD -7.8MSEC XBRL filing
- Operating cash flow (annual): USD -2.94MSEC XBRL filing